Ronda Stryker Net Worth – How Much is Stryker Worth?

Ronda Stryker, the granddaughter of Stryker Corporation’s founder, is not just a successful businesswoman but also a billionaire. As an independent director of Stryker Corporation and the company’s largest individual shareholder, Ronda Stryker has amassed a staggering net worth. Her estimated net worth in 2023 stands at a whopping $6.0 billion, firmly placing her among the elite billionaires of the world.

Key Takeaways

Ronda Stryker’s net worth is estimated to be $6.0 billion.
She serves as an independent director of Stryker Corporation.
Ronda Stryker is the largest individual shareholder of the company.
Her wealth highlights her significant impact in the medical technology field.
Ronda Stryker’s success exemplifies her valuable contributions to the business world.

Ronda Stryker Biography

Ronda Stryker is a prominent figure in the medical technology industry. She has served as an Independent Director of Stryker Corporation since 1984 and is also the Vice Chair of Greenleaf Trust, a Michigan chartered bank. In addition, she holds the position of Vice Chair at Spelman College. With a strong interest in advocating for diversity and social responsibility, Stryker brings a unique perspective to the board of directors.

As a member of the founding family and the largest individual shareholder, Ronda Stryker’s contributions to Stryker Corporation are invaluable. Her deep understanding of the company’s history and values, coupled with her extensive experience in the medical field, make her an asset to the board. Stryker’s passion for advancing healthcare and improving patient outcomes is evident in her dedication to promoting diversity and social responsibility within the industry.

Throughout her career, Ronda Stryker has demonstrated a commitment to driving positive change. Her contributions extend beyond Stryker Corporation, as she actively engages in philanthropic efforts to support education and healthcare initiatives. With her wealth and influence, Stryker continues to make a significant impact in both the business world and the community at large.

“I believe that it is our responsibility to use our resources and influence to create positive change in the world. That’s why diversity, equality, and social responsibility are at the core of everything I do.” – Ronda Stryker

Ronda Stryker Salary and Compensation

Ronda Stryker, as an Independent Director of Stryker Corporation, receives a total compensation of $290,107. While her salary may not be amongst the highest in the company, it is important to note that Ronda Stryker’s role goes beyond a mere monetary figure. As the largest individual shareholder, her presence on the board adds significant value and insight.

While the executives at Stryker Corporation may receive higher compensation, Ronda Stryker’s unique position as both a shareholder and an Independent Director brings a wealth of experience and expertise to the table. Her compensation reflects not only her role as a director but also the invaluable perspective she provides as a member of the founding family.

It is worth noting that Ronda Stryker’s compensation is just one aspect of her overall wealth and influence within the company. Her significant ownership of Stryker Corporation stock further contributes to her status as a billionaire and underscores the impact she has on the company’s success.

Position
Total Compensation

Ronda Stryker
$290,107

CEO
$13,317,032

CFO
$4,345,853

Ronda Stryker’s Impact on Stryker Corporation

Ronda Stryker’s compensation is just one element of her overall significance within Stryker Corporation. Her role as an Independent Director allows her to contribute her unique shareholder perspective and advocate for diversity and social responsibility within the organization.

Her influence goes beyond monetary compensation, as her ownership of approximately 10% of the company’s stock further solidifies her impact on Stryker Corporation’s strategic direction and long-term success. As the largest individual shareholder, her voice carries weight and influences decision-making processes within the company.

Ronda Stryker’s contributions to the medical technology field extend beyond her compensation and ownership. Her commitment to diversity, social responsibility, and the advancement of healthcare technologies make her a key figure in the industry and a driving force within Stryker Corporation.

Ronda Stryker Net Worth by Holdings

One of the key factors contributing to Ronda Stryker’s impressive net worth is her significant holdings in Stryker Corporation. As the largest individual shareholder, she owns approximately 20,619,378 shares of the company’s stock, representing about 10% ownership. Based on the current stock price, her holdings are valued at around $6.0 billion.

This substantial ownership in Stryker Corporation highlights Ronda Stryker’s deep commitment to the company and her confidence in its future growth. It also serves as a testament to her strong belief in the value of the company’s products and its potential to make a positive impact in the medical technology field.

Holdings
Ownership
Value

Stryker Corporation Stock
Approximately 10%
$6.0 billion

Ronda Stryker’s substantial stock ownership not only contributes to her impressive net worth but also gives her a vested interest in the company’s success. It aligns her financial well-being with the company’s performance, ensuring that her goals are aligned with those of the shareholders.

“I am proud to be a long-term shareholder of Stryker Corporation. The company’s commitment to innovation, quality, and patient care is what sets it apart in the medical technology industry. I am confident in the company’s ability to continue delivering value to its shareholders.”

Overall, Ronda Stryker’s significant holdings in Stryker Corporation underscore her prominence in the company and her belief in its long-term growth potential. Her stock ownership not only contributes to her net worth but also solidifies her position as a dedicated shareholder and influential figure in the medical technology industry.

Stryker Corporation Overview

Stryker Corporation is a renowned medical technology company headquartered in Kalamazoo, Michigan. With a strong focus on innovation and quality, Stryker Corp has established itself as a leader in the healthcare industry. The company operates through two main segments: MedSurg and Neurotechnology, and Orthopaedics and Spine.

The MedSurg and Neurotechnology segment offers a wide range of medical devices and equipment for various specialties. This includes surgical equipment, navigation systems, and neurotechnology products that are designed to enhance patient outcomes and improve the efficiency of healthcare professionals.

The Orthopaedics and Spine segment of Stryker Corp is dedicated to providing innovative solutions for joint replacements and the treatment of spinal disorders. The company offers a comprehensive portfolio of orthopaedic implants, surgical equipment, and advanced technologies that aim to improve mobility and alleviate pain for patients.

Key Highlights:

Stryker Corporation is a leading global medical technology company.
The company operates through two segments: MedSurg and Neurotechnology, and Orthopaedics and Spine.

Stryker Corp offers a wide range of medical devices and equipment for various specialties, including surgical equipment, navigation systems, and neurotechnology products.
The Orthopaedics and Spine segment provides innovative solutions for joint replacements and the treatment of spinal disorders.

Table: Stryker Corporation Overview

Headquarters
Kalamazoo, Michigan

Segments
MedSurg and Neurotechnology, Orthopaedics and Spine

Product Offerings
Medical devices, surgical equipment, navigation systems, neurotechnology products, orthopaedic implants

Main Focus
Enhancing patient outcomes, improving the efficiency of healthcare professionals, improving mobility, and alleviating pain for patients

Stryker Corp Key Executives

Stryker Corporation is led by a team of experienced and dedicated executives who play a crucial role in the company’s success. Let’s take a closer look at some of the key executives at Stryker Corp:

Kevin Lobo – Chairman and CEO

Kevin Lobo has been serving as the Chairman and CEO of Stryker Corporation since 2012. With over 25 years of experience in the medical technology industry, Lobo has been instrumental in driving the company’s growth and expansion. Under his leadership, Stryker has consistently delivered innovative solutions that enhance patient care and improve outcomes.

Viju Menon – Group President

Viju Menon is the Group President at Stryker Corporation and oversees the company’s global operations. With a strong background in finance and a deep understanding of the healthcare industry, Menon plays a key role in driving operational excellence and achieving business objectives. His strategic vision and leadership have been instrumental in Stryker’s continued success.

Robert Fletcher – Vice President and Chief Legal Officer

Robert Fletcher serves as the Vice President and Chief Legal Officer at Stryker Corporation. With his extensive legal expertise and deep knowledge of the medical technology industry, Fletcher plays a crucial role in ensuring compliance with regulations and managing legal risks. His dedication to upholding ethical standards helps maintain Stryker’s reputation as a trusted and responsible company.

These key executives, along with the rest of the leadership team at Stryker Corporation, bring a wealth of experience and expertise to the table. Their strategic guidance and commitment to innovation have positioned the company as a global leader in the medical technology industry.

Stryker Corp Insider Ownership and Ronda Stryker’s Stake

When it comes to insider ownership at Stryker Corporation, Ronda Stryker stands out as one of the key stakeholders. As an Independent Director of the company, she holds a significant number of shares, making her an influential figure in the decision-making processes. Alongside Ronda Stryker, other notable insiders and stock owners include CEO Kevin Lobo, President Timothy Scannell, and CFO Glenn Boehnlein, among others.

Having insiders with substantial ownership is a positive sign for investors, as it demonstrates their confidence and commitment to the company’s success. Ronda Stryker’s significant stake in Stryker Corporation reflects her long-standing association with the company and her belief in its future prospects.

To gain a better understanding of insider ownership at Stryker Corp, let’s take a look at the table below:

Name
Title
Number of Shares

Ronda Stryker
Independent Director
20,619,378

Kevin Lobo
CEO
478,521

Timothy Scannell
President
108,610

Glenn Boehnlein
CFO
156,872

Other insiders
–
Various

As the table illustrates, Ronda Stryker’s ownership surpasses that of other insiders, highlighting the importance of her role within the company. Her significant stake is an affirmation of the trust and confidence she places in Stryker Corporation’s growth and future prospects.

Ronda Stryker’s Transactions and Ownership Reports

Ronda Stryker, as an insider at Stryker Corporation, has been involved in various transactions and has provided ownership reports over the past few years. These activities offer insights into her involvement with the company and contribute to her overall net worth. Let’s take a closer look at Ronda Stryker’s insider transactions and stock ownership.

Insider Transactions

Ronda Stryker has made significant insider transactions at Stryker Corporation, demonstrating her active involvement in the company. Over the past five years, she has sold a considerable number of shares, which has contributed to her wealth and overall net worth. These transactions provide a glimpse into her investment decisions and actions as a key insider.

Ownership Reports

As the largest individual shareholder of Stryker Corporation, Ronda Stryker regularly provides ownership reports. These reports detail her holdings in the company, showcasing her substantial stock ownership. Currently, she owns approximately 20,619,378 shares of Stryker Corp stock, with a total value of $6.0 billion. These reports demonstrate her significant influence and investment in the company.

Ronda Stryker’s Stock Ownership

Ronda Stryker’s stock ownership in Stryker Corporation plays a significant role in her overall net worth. With approximately 10% ownership of the company, her holdings contribute significantly to her wealth. As a key insider and the largest individual shareholder, her stock ownership represents her confidence and commitment to the company’s success.

Stryker Corp Executive Compensation

Executive compensation is an essential aspect of Stryker Corporation’s corporate governance. It reflects the recognition and value placed on the roles and responsibilities of key executives within the company. Key executives, such as CEO Kevin Lobo and CFO Glenn Boehnlein, receive competitive compensation packages that align with their contributions and the company’s performance.

In 2020, CEO Kevin Lobo received a total compensation package amounting to $13,317,032. This compensation includes base salary, bonuses, stock awards, and other benefits. The compensation for CFO Glenn Boehnlein in the same year was $4,345,853. These figures highlight the significance of these executives and their impact on the company’s success.

It is important to note that executive compensation is not solely based on financial performance. Factors such as individual performance, leadership, and strategic decision-making also play a role in determining compensation. These compensation packages aim to attract and retain top talent, motivating executives to drive the company’s growth and enhance shareholder value.

Key Takeaways:

Executive compensation at Stryker Corporation reflects the value placed on key executives and their contributions to the company.
In 2020, CEO Kevin Lobo received a total compensation package of $13,317,032, while CFO Glenn Boehnlein received $4,345,853.
Executive compensation is determined by factors such as financial performance, individual performance, leadership, and strategic decision-making.
These compensation packages aim to attract and retain top talent, motivating executives to drive the company’s growth and enhance shareholder value.

Ronda Stryker’s Mailing Address

If you need to reach out to Ronda Stryker, you can contact her at the following mailing address:

Ronda Stryker
2825 Airview Blvd
Kalamazoo, MI 49002

By using this address, you can send any correspondence or inquiries related to her role as an Independent Director of Stryker Corporation.

Ronda Stryker, as the largest individual shareholder of the company and a member of the founding family, brings unique perspectives and insights to the board. Her success and significant ownership in Stryker Corporation highlight her impact on the company and the medical technology field as a whole.

Although Ronda Stryker has made insider transactions over the past 5 years, selling a significant number of shares, her role as an Independent Director adds substantial value to the board. Her contributions, combined with her wealth and influence, make her an influential figure within the company.

Stryker Corp Insider Trading Summary

Insider trading plays a significant role in the activities of executives and key insiders at Stryker Corporation. Understanding the insider trading activities can provide valuable insights into the market sentiments and decisions made by those who have a deep understanding of the company. Over the past 18 months, one notable insider transaction has been made by Ronda Stryker, a prominent figure within the corporation.

“Insider trading provides valuable insights into the market sentiments and decisions made by those who have a deep understanding of the company.”

Ronda Stryker, as an insider and the largest individual shareholder, possesses intimate knowledge about the inner workings of Stryker Corporation. Her insider transaction involved the sale of 520,000 shares, demonstrating her engagement in the company’s stock activities. While additional details about the transaction are not available, this transaction sheds light on the actions and decisions of key insiders within the corporation.

To gain a comprehensive understanding of the insider trading activities within Stryker Corporation, it is important to consider the actions of other key insiders as well. Executives such as Kevin Lobo, Timothy Scannell, and Glenn Boehnlein also partake in insider trading, influencing market perceptions and potential investment decisions. By analyzing the patterns and trends of insider trading, investors and analysts can gain valuable insights into the dynamics and movements of the company’s stock.

Conclusion

In conclusion, Ronda Stryker’s impact on Stryker Corporation cannot be overstated. As the largest individual shareholder and an Independent Director, she brings immense value to the company’s board. Her estimated net worth of $6.0 billion solidifies her position as a billionaire and further emphasizes her influence in the medical technology field.

Not only does Ronda Stryker possess significant wealth, but she also holds approximately 10% ownership of Stryker Corporation. Her stock holdings, valued at around $6.0 billion, contribute significantly to her overall net worth and highlight her commitment to the company’s success.

As a member of the founding family and a strong advocate for diversity and social responsibility, Ronda Stryker provides a unique shareholder perspective to the board. Her contributions and insights are invaluable, ensuring the company’s continued growth and innovation in the medical technology industry.

The post Ronda Stryker Net Worth – How Much is Stryker Worth? appeared first on Zac Johnson.